1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc.

INKT
MiNK Therapeutics, Inc.US flagNASDAQ Capital Market
12.76
USD
+0.80
- -
63.57MMarket Cap

Income Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
1
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
1
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
-1
- -
- -
- -
- -
- -
- -
- Operating Expenses
23
15
19
31
23
11
12
+ Selling, General & Admin
4
1
5
8
7
4
7
+ Research & Development
20
10
14
23
15
6
6
+ Other Operating Expense
-1
4
- -
- -
- -
- -
- -
Operating Income (Loss)
-22
-15
-19
-31
-23
-11
-12
- Non-Operating (Income) Loss
2
2
12
-3
- -
- -
- -
+ Interest Expense, Net
2
2
2
- -
- -
- -
- -
+ Interest Expense
2
2
2
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
-1
9
-3
- -
- -
- -
Pretax Income
-24
-16
-30
-28
-22
-11
-12
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-24
-16
-30
-28
-22
-11
-12
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-24
-16
-30
-28
-22
-11
-12
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-24
-16
-30
-28
-22
-11
-12
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-24
-16
-30
-28
-22
-11
-12
EBIT
-22
-15
-19
-31
-23
-11
-12
EBITDA
-22
-15
-19
-31
-23
-10
-12
EBITDA Margin (%)
-3,226.05
- -
- -
- -
- -
- -
- -
EBITA
-22
-15
-19
-31
-23
-11
-12
Gross Margin (%)
100
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-3,231.39
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-3,451.46
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
3
3
3
3
3
4
4
Basic EPS, GAAP
-9.32
-5.72
-11.61
-8.31
-6.54
-2.86
-2.93
Basic EPS from Cont Ops
-9.32
-5.72
-11.61
-8.31
-6.54
-2.86
-2.93
Diluted Weighted Avg Shares
3
3
3
3
3
4
4
Diluted EPS, GAAP
-9.32
-5.72
-11.61
-8.31
-6.54
-2.86
-2.93
Diluted EPS from Cont Ops
-9.32
-5.72
-11.61
-8.31
-6.54
-2.86
-2.93

Balance Sheet (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
1
4
40
20
4
5
14
+ Cash, Cash Equivalents & STI
- -
3
39
20
3
5
13
+ Cash & Cash Equivalents
- -
3
39
20
3
5
13
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
1
1
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
1
1
1
- -
+ Property, Plant & Equip, Net
- -
- -
1
1
1
1
- -
+ Property, Plant & Equip
- -
1
1
1
1
1
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
1
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
1
5
40
21
5
6
14
+ Payables & Accruals
7
9
11
10
9
5
5
+ Accounts Payable
2
3
3
6
4
3
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
5
5
8
4
5
2
2
+ ST Debt
- -
- -
- -
- -
- -
- -
5
+ ST Borrowings
- -
- -
- -
- -
- -
- -
5
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
6
6
3
2
2
3
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
6
6
3
2
2
3
Total Current Liabilities
7
14
16
13
11
7
13
+ LT Debt
27
44
- -
- -
- -
5
- -
+ LT Borrowings
27
44
- -
- -
- -
5
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
3
- -
- -
9
11
13
15
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
3
- -
- -
9
11
13
15
Total Noncurrent Liabilities
30
44
- -
9
11
18
15
Total Liabilities
38
58
16
22
23
25
28
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
107
111
116
125
143
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
107
111
116
125
143
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-36
-53
-83
-111
-133
-144
-157
+ Other Equity
- -
-2
-1
- -
- -
-1
-1
Equity Before Minority Interest
-36
-54
24
- -
-18
-20
-14
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-36
-54
24
- -
-18
-20
-14
Total Liabilities & Equity
1
5
40
21
5
6
14
Shares Outstanding
3
3
3
3
3
4
5
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
Net Debt
26
41
-39
-20
-3
- -
-8
Net Debt to Equity
-72.91
-76.35
-163.56
4,892.99
18.65
-1.77
57.5
Tangible Common Equity Ratio
-2,775.86
-1,182.7
59.08
-1.87
-396.62
-342.36
-99.92
Current Ratio
0.12
0.29
2.41
1.61
0.32
0.72
1.06
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-24
-16
-30
-28
-22
-11
-12
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
5
8
14
- -
4
1
3
+ Stock-Based Compensation
- -
- -
2
3
4
2
3
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
4
8
12
-3
- -
-1
- -
+ Chg in Non-Cash Work Cap
4
- -
4
9
3
- -
3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
1
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
2
- -
- -
6
- -
-2
1
+ Inc (Dec) in Other
1
- -
3
3
3
2
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-15
-8
-13
-19
-16
-10
-6
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
40
- -
- -
6
14
+ Increase in Capital Stock
- -
- -
40
- -
- -
6
14
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
23
22
19
- -
- -
5
- -
+ Cash From Debt
23
22
19
- -
- -
5
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
-11
-11
-9
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
11
11
49
- -
- -
11
15
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-4
3
36
-19
-16
1
9
EBITDA
-22
-15
-19
-31
-23
-10
-12
EBITDA Margin (%)
-3,226.05
- -
- -
- -
- -
- -
- -
Free Cash Flow
-15
-8
-13
-19
-16
-10
-6
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
13
6
-19
-16
-5
-6
Free Cash Flow per Basic Share
-6.02
-2.97
-5.02
-5.68
-4.61
-2.53
-1.39
Price/Free Cash Flow
- -
- -
-9.23
-4.72
-2.34
-2.75
-8.04
Cash Flow to Net Income
0.63
0.51
0.42
0.67
0.7
0.89
0.47
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -